Garden Stage (GSIW) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Operates as a holding company incorporated in the Cayman Islands, with all operations conducted through wholly-owned subsidiaries in Hong Kong focused on financial services including securities brokerage, underwriting, asset management, and investment advisory.
Subsidiaries are fully licensed by the Hong Kong Securities and Futures Commission for regulated activities, with no operations or subsidiaries in Mainland China.
Revenue streams are diversified across placing and underwriting, securities dealing, asset management, and advisory services, targeting both local and international clients.
The business model leverages synergies among service lines to generate stable and diversified revenue.
Financial performance and metrics
Reported revenues of $1.4 million for the year ended March 31, 2024, down from $3.3 million in the prior year.
Net loss increased to $4.7 million for the year ended March 31, 2024, compared to a net loss of $0.2 million in the previous year.
No dividends or distributions have been declared or paid to shareholders or by subsidiaries as of the date of the prospectus.
Use of proceeds and capital allocation
Net proceeds from securities offerings will be used as indicated in applicable prospectus supplements, with a stated intention to retain future earnings for business expansion.
No present plans to declare or pay dividends; future dividend policy will depend on financial condition, results, and capital requirements.
Latest events from Garden Stage
- Revenue surged but losses widened on higher costs; major capital raise and acquisition announced.GSIW
H1 202620 Jan 2026 - Hong Kong-based financial services firm seeks to raise up to $100M amid regulatory and market risks.GSIW
Registration Filing16 Dec 2025 - Form F-3 enables ongoing U.S. offerings, led by Sze Ho Chan, with robust governance.GSIW
Registration Filing16 Dec 2025 - FY2024 revenue dropped 56.8% and net loss widened to $4.6M amid lower deal flow and higher costs.GSIW
H2 202412 Dec 2025 - Resale of 1,750,000 shares by the controlling shareholder, no proceeds to the company.GSIW
Registration Filing29 Nov 2025 - Resale of 1,750,000 shares by a controlling shareholder amid regulatory and financial headwinds.GSIW
Registration Filing29 Nov 2025